Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience

1Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, et al. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group. Blood 2018; 132: 815-24. doi: 10.1182/blood-2018-04-841676Roberts KG Reshmi SC Harvey RC Chen IM Patel K Stonerock E et al Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group Blood 2018 132 815 24 10.1182/blood-2018-04-841676Open DOISearch in Google Scholar

2Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 2012; 30: 1663-9. doi: 10.1200/JCO.2011.37.8018Hunger SP Lu X Devidas M Camitta BM Gaynon PS Winick NJ et al Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group J Clin Oncol 2012 30 1663 9 10.1200/JCO.2011.37.8018Open DOISearch in Google Scholar

3Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64: 83-103. doi: 10.3322/caac.21219Ward E DeSantis C Robbins A Kohler B Jemal A Childhood and adolescent cancer statistics, 2014 CA Cancer J Clin 2014 64 83 103 10.3322/caac.21219Open DOISearch in Google Scholar

4Einsiedel HG, Von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, et al. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87. J Clin Oncol 2005; 23: 7942-50. doi: 10.1200/JCO.2005.01.1031Einsiedel HG Von Stackelberg A Hartmann R Fengler R Schrappe M Janka-Schaub G et al Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87 J Clin Oncol 2005 23 7942 50 10.1200/JCO.2005.01.1031Open DOISearch in Google Scholar

5Olsson L, Ivanov Öfverholm II, Norén-Nyström U, Zachariadis V, Nordlund J, Sjögren H, et al. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 aand 1993. Br J Haematol 2015; 170: 847-58. doi: 10.1111/bjh.13514Olsson L Ivanov Öfverholm II Norén-Nyström U Zachariadis V Nordlund J Sjögren H et al The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 aand 1993 Br J Haematol 2015 170 847 58 10.1111/bjh.13514Open DOISearch in Google Scholar

6Dörge P, Meissner B, Zimmermann M, Möricke A, Schrauder A, Bouquin JP, et al. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica 2013; 98: 428-32. doi: 10.3324/haematol.2011.056135Dörge P Meissner B Zimmermann M Möricke A Schrauder A Bouquin JP et al IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol Haematologica 2013 98 428 32 10.3324/haematol.2011.056135Open DOISearch in Google Scholar

7Asai D, Imamura T, Suenobu S, Saito A, Hasegawa D, Deguchi T, et al. IKZF 1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Cancer Med 2013; 2: 412-9. doi: 10.1002/cam4.87Asai D Imamura T Suenobu S Saito A Hasegawa D Deguchi T et al IKZF 1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan Cancer Med 2013 2 412 9 10.1002/cam4.87Open DOISearch in Google Scholar

8Kuiper RP, Waanders E, Van Der Velden VHJ, Van Reijmersdal SV, Venkatachalam R, Scheijen B, et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 2010; 24: 1258-64. doi: 10.1038/leu.2010.87Kuiper RP Waanders E Van Der Velden VHJ Van Reijmersdal SV Venkatachalam R Scheijen B et al IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL Leukemia 2010 24 1258 64 10.1038/leu.2010.87Open DOISearch in Google Scholar

9Mullighan CG, Su X, Zhang J, Radtke I, Phillips LAA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360: 470-80. doi: 10.1056/NEJMoa0808253Mullighan CG Su X Zhang J Radtke I Phillips LAA Miller CB et al Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia N Engl J Med 2009 360 470 80 10.1056/NEJMoa0808253Open DOISearch in Google Scholar

10Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, et al. The ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79: 143-56. doi: 10.1016/0092-8674(94)90407-3Georgopoulos K Bigby M Wang JH Molnar A Wu P Winandy S et al The ikaros gene is required for the development of all lymphoid lineages Cell 1994 79 143 56 10.1016/0092-8674(94)90407-3Open DOISearch in Google Scholar

11Molnar A, Wu P, Largespada DA, Vortkamp A, Scherer S, Copeland NG, et al. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J Immunol 1996; 156: 585-92. PMID: 8543809Molnar A Wu P Largespada DA Vortkamp A Scherer S Copeland NG et al The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse J Immunol 1996 156 585 92 PMID: 854380910.4049/jimmunol.156.2.585Search in Google Scholar

12Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, Hsiao CC, et al. IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci 2011; 102: 1874-81. doi: 10.1111/j.1349-7006.2011.02031.xYang YL Hung CC Chen JS Lin KH Jou ST Hsiao CC et al IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan Cancer Sci 2011 102 1874 81 10.1111/j.1349-7006.2011.02031.x21740479Open DOISearch in Google Scholar

13Van Der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal S V., Russell LJ, et al. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood 2013; 122: 2622-9. doi: 10.1182/blood-2012-10-462358Van Der Veer A Waanders E Pieters R Willemse ME Van Reijmersdal S V Russell LJ et al Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL Blood 2013 122 2622 9 10.1182/blood-2012-10-462358379546123974192Open DOISearch in Google Scholar

14Moorman A V., Enshaei A, Schwab C, Wade R, Chilton L, Elliott A, et al. A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. Blood 2014; 124: 1434-44. doi: 10.1182/blood-2014-03-562918Moorman A V. Enshaei A Schwab C Wade R Chilton L Elliott A et al A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia Blood 2014 124 1434 44 10.1182/blood-2014-03-56291824957142Open DOISearch in Google Scholar

15Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110-14. doi: 10.1038/nature06866Mullighan CG Miller CB Radtke I Phillips LA Dalton J Ma J et al BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros Nature 2008 453 110 14 10.1038/nature0686618408710Open DOISearch in Google Scholar

16Van Der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, Te Kronnie G, Harrison CJ, et al. IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. Blood 2014; 123: 1691-8. doi: 10.1182/blood-2013-06-509794Van Der Veer A Zaliova M Mottadelli F De Lorenzo P Te Kronnie G Harrison CJ et al IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL Blood 2014 123 1691 8 10.1182/blood-2013-06-50979424366361Open DOISearch in Google Scholar

17Roberts KG. The biology of Philadelphia chromosome-like ALL. Best Pract Res Clin Haematol 2017; 30: 212-21. doi: 10.1016/j.beha.2017.07.003Roberts KG The biology of Philadelphia chromosome-like ALL Best Pract Res Clin Haematol 2017 30 212 21 10.1016/j.beha.2017.07.00329050694Open DOISearch in Google Scholar

18Boer JM, Van Der Veer A, Rizopoulos D, Fiocco M, Sonneveld E, De Groot-Kruseman HA, et al. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. Leukemia 2016; 30: 32-38. doi: 10.1038/leu.2015.199Boer JM Van Der Veer A Rizopoulos D Fiocco M Sonneveld E De Groot-Kruseman HA et al Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study Leukemia 2016 30 32 38 10.1038/leu.2015.19926202931Open DOISearch in Google Scholar

19Steeghs EMP, Boer JM, Hoogkamer AQ, Boeree A, de Haas V, de Groot-Kruseman HA, et al. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Sci Rep 2019; 9: 1-11. doi: 10.1038/s41598-019-41078-4Steeghs EMP Boer JM Hoogkamer AQ Boeree A de Haas V de Groot-Kruseman HA et al Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia Sci Rep 2019 9 1 11 10.1038/s41598-019-41078-4642065930874617Open DOISearch in Google Scholar

20Stanulla M, Cavé H, Moorman A V. IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? Blood 2020; 135: 252-60. doi: 10.1182/blood.2019000813Stanulla M Cavé H Moorman A V IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? Blood 2020 135 252 60 10.1182/blood.2019000813701903531821407Open DOISearch in Google Scholar

21Stanulla M, Dagdan E, Zaliova M, Möricke A, Palmi C, Cazzaniga G, et al. IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia. J Clin Oncol 2018; 36: 1240-9. doi: 10.1200/JCO.2017.74.3617Stanulla M Dagdan E Zaliova M Möricke A Palmi C Cazzaniga G et al IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia J Clin Oncol 2018 36 1240 9 10.1200/JCO.2017.74.361729498923Open DOISearch in Google Scholar

22Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 2019; 51: 296-307. doi: 10.1038/s41588-018-0315-5Gu Z Churchman ML Roberts KG Moore I Zhou X Nakitandwe J et al PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Nat Genet 2019 51 296 307 10.1038/s41588-018-0315-5652530630643249Open DOISearch in Google Scholar

23Schwab C, Nebral K, Chilton L, Leschi C, Waanders E, Boer JM, et al. Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? Blood Adv 2017; 1: 1473-7. doi: 10.1182/bloodadvances.2017006734Schwab C Nebral K Chilton L Leschi C Waanders E Boer JM et al Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? Blood Adv 2017 1 1473 7 10.1182/bloodadvances.2017006734572846229296789Open DOISearch in Google Scholar

24Zhang W, Kuang P, Liu T. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis. Ann Med 2019; 51: 28-40. doi: 10.1080/07853890.2018.1564359Zhang W Kuang P Liu T Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis Ann Med 2019 51 28 40 10.1080/07853890.2018.1564359785747330592434Open DOISearch in Google Scholar

25Carrasco Salas P, Fernández L, Vela M, Bueno D, González B, Valentín J, et al. The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia. Pediatr Hematol Oncol 2016; 33: 415-22. doi: 10.1080/08880018.2016.1251518Carrasco Salas P Fernández L Vela M Bueno D González B Valentín J et al The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia Pediatr Hematol Oncol 2016 33 415 22 10.1080/08880018.2016.125151827960642Open DOISearch in Google Scholar

26Zhang W, Kuang P, Liu T. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis. Ann Med 2019; 51: 28-40. doi: 10.1080/07853890.2018.1564359Zhang W Kuang P Liu T Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis Ann Med 2019 51 28 40 10.1080/07853890.2018.1564359Open DOISearch in Google Scholar

27Yamashita Y, Shimada A, Yamada T, Yamaji K, Hori T, Tsurusawa M, et al. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in japanese BCR-ABL1-negative high-risk B-cell precursor acute. Pediatr Blood Cancer 2013; 60: 1587-92. doi: 10.1002/pbcYamashita Y Shimada A Yamada T Yamaji K Hori T Tsurusawa M et al IKZF1 and CRLF2 gene alterations correlate with poor prognosis in japanese BCR-ABL1-negative high-risk B-cell precursor acute Pediatr Blood Cancer 2013 60 1587 92 10.1002/pbcOpen DOISearch in Google Scholar

28Palmi C, Valsecchi MG, Longinotti G, Silvestri D, Carrino V, Conter V, et al. What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? Haematologica 2013; 98: 1226-31. doi: 10.3324/haematol.2012.075432Palmi C Valsecchi MG Longinotti G Silvestri D Carrino V Conter V et al What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? Haematologica 2013 98 1226 31 10.3324/haematol.2012.075432372990223585525Open DOISearch in Google Scholar

29Clappier E, Grardel N, Bakkus M, Rapion J, De Moerloose B, Kastner P, et al. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children’s Leukemia Group study 58951. Leukemia 2015; 29: 2154-61. doi: 10.1038/leu.2015.134Clappier E Grardel N Bakkus M Rapion J De Moerloose B Kastner P et al IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children’s Leukemia Group study 58951 Leukemia 2015 29 2154 61 10.1038/leu.2015.13426050650Open DOISearch in Google Scholar

30Vrooman LM, Blonquist TM, Harris MH, Stevenson KE, Place AE, Hunt SK, et al. Refining risk classification in childhood b acute lymphoblastic leukemia: results of DFCI ALL consortium protocol 05-001. Blood Adv 2018; 2: 144958. doi: 10.1182/bloodadvances.2018016584Vrooman LM Blonquist TM Harris MH Stevenson KE Place AE Hunt SK et al Refining risk classification in childhood b acute lymphoblastic leukemia: results of DFCI ALL consortium protocol 05-001 Blood Adv 2018 2 144958 10.1182/bloodadvances.2018016584602080629941458Open DOISearch in Google Scholar

31Öfverholm I, Tran AN, Heyman M, Zachariadis V, Nordenskjöld M, Nordgren A, et al. Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols. Leukemia 2013; 27: 1936-9. doi: 10.1038/leu.2013.92Öfverholm I Tran AN Heyman M Zachariadis V Nordenskjöld M Nordgren A et al Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols Leukemia 2013 27 1936 9 10.1038/leu.2013.9223538749Open DOISearch in Google Scholar

32Schwab CJ, Jones LR, Morrison H, Ryan SL, Yigittop H, Schouten JP, et al. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosom Cancer 2010; 49: 1104-13. doi: 10.1002/gccSchwab CJ Jones LR Morrison H Ryan SL Yigittop H Schouten JP et al Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia Genes Chromosom Cancer 2010 49 1104 13 10.1002/gccOpen DOISearch in Google Scholar

33Schwab CJ, Chilton L, Morrison H, Jones L, Al-Shehhi H, Erhorn A, et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica 2013; 98: 1081-8. doi: 10.3324/haematol.2013.085175Schwab CJ Chilton L Morrison H Jones L Al-Shehhi H Erhorn A et al Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features Haematologica 2013 98 1081 8 10.3324/haematol.2013.085175369661223508010Open DOISearch in Google Scholar

34Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758-64. doi: 10.1038/nature05690Mullighan CG Goorha S Radtke I Miller CB Coustan-Smith E Dalton JD et al Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Nature 2007 446 758 64 10.1038/nature0569017344859Open DOISearch in Google Scholar

35Kim M, Choi JE, She CJ, Hwang SM, Shin HY, Ahn HS, et al. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia. Blood Cells, Mol Dis 2011; 47: 62-6. doi: 10.1016/j.bcmd.2011.04.003Kim M Choi JE She CJ Hwang SM Shin HY Ahn HS et al PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia Blood Cells, Mol Dis 2011 47 62 6 10.1016/j.bcmd.2011.04.00321549623Open DOISearch in Google Scholar

36Kawamata N, Ogawa S, Zimmermann M, Sanada M, Hemminki K, Yamatomo G, et al. Rearrangement and deletion of the PAX5 gene in pediatric acute B-cell lineage lymphoblastic leukemia. Blood 2007; 110: 981. doi: 10.1182/blood.V110.11.981.981Kawamata N Ogawa S Zimmermann M Sanada M Hemminki K Yamatomo G et al Rearrangement and deletion of the PAX5 gene in pediatric acute B-cell lineage lymphoblastic leukemia Blood 2007 110 981 10.1182/blood.V110.11.981.981Open DOISearch in Google Scholar

37Kim M, Choi JE, She CJ, Hwang SM, Shin HY, Ahn HS, et al. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia. Blood Cells, Mol Dis 2011; 47: 62-6. doi: 10.1016/j.bcmd.2011.04.003Kim M Choi JE She CJ Hwang SM Shin HY Ahn HS et al PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia Blood Cells, Mol Dis 2011 47 62 6 10.1016/j.bcmd.2011.04.003Open DOISearch in Google Scholar

38Paulsson K, Johansson B. High Hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosom Cancer 2009; 48: 637-60. doi: 10.1002/gcc.20671Paulsson K Johansson B High Hyperdiploid childhood acute lymphoblastic leukemia Genes Chromosom Cancer 2009 48 637 60 10.1002/gcc.2067119415723Open DOISearch in Google Scholar

39Palmi C, Vendramini E, Silvestri D, Longinotti G, Frison D, Cario G, et al. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. Leukemia 2012; 26: 2245-53. doi: 10.1038/leu.2012.101Palmi C Vendramini E Silvestri D Longinotti G Frison D Cario G et al Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia Leukemia 2012 26 2245 53 10.1038/leu.2012.10122484421Open DOISearch in Google Scholar